Literature DB >> 12678834

Aminoglycoside and its derivatives as ligands to target the ribosome.

Jeffrey B-H Tok1, Lanrong Bi.   

Abstract

Protein synthesis is a central function in cellular physiology, and this important process is the target of many naturally occurring antibiotics and toxins. One such antibiotic is the aminoglycoside, which has been widely utilized in the clinical in the last fifty years due to their low cost and reliable activities. However the usage and applications of aminoglycosides have been severely limited due to their numerous side effects and resistance mechanism acquired by bacteria. Advances in understanding their mechanism of action have led to attempts in developing novel aminoglycoside-derivatives that would potentially eliminate harmful side effects and be resistant to aminoglycoside-modifying enzymes. This account provides a brief introduction to the various classes of antibiotics that target the ribosome, and also provide highlights in recent advancement of the synthesis of aminoglycoside analogs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678834     DOI: 10.2174/1568026033452131

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  8 in total

Review 1.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 2.  Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases.

Authors:  Kim M Keeling; David M Bedwell
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-07-06       Impact factor: 9.957

3.  Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54.

Authors:  Steven M Rowe; Peter Sloane; Li Ping Tang; Kyle Backer; Marina Mazur; Jessica Buckley-Lanier; Igor Nudelman; Valery Belakhov; Zsuzsa Bebok; Erik Schwiebert; Timor Baasov; David M Bedwell
Journal:  J Mol Med (Berl)       Date:  2011-07-22       Impact factor: 4.599

Review 4.  Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis.

Authors:  Peter A Sloane; Steven M Rowe
Journal:  Curr Opin Pulm Med       Date:  2010-11       Impact factor: 3.155

5.  The use of aminoglycoside derivatives to study the mechanism of aminoglycoside 6'-N-acetyltransferase and the role of 6'-NH2 in antibacterial activity.

Authors:  Xuxu Yan; Feng Gao; Sirilata Yotphan; Parseh Bakirtzian; Karine Auclair
Journal:  Bioorg Med Chem       Date:  2007-02-11       Impact factor: 3.641

6.  Restoration of W1282X CFTR activity by enhanced expression.

Authors:  Steven M Rowe; Karoly Varga; Andras Rab; Zsuzsa Bebok; Kevin Byram; Yao Li; Eric J Sorscher; John P Clancy
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-31       Impact factor: 6.914

7.  No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.

Authors:  John P Clancy; Steven M Rowe; Zsuzsa Bebok; Moira L Aitken; Ron Gibson; Pam Zeitlin; Pierre Berclaz; Rick Moss; Michael R Knowles; Robert A Oster; Nicole Mayer-Hamblett; Bonnie Ramsey
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-08       Impact factor: 6.914

8.  Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.

Authors:  Dustin T King; Mark Barnes; Dana Thomsen; Chow H Lee
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.